Liver Failure: Clinical Trials

15 trials for Liver Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 unknown. 15 Phase 1, 12 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 115Unknown 15
Phase 212Unknown 12

Follow Liver Failure: new trials by email Literature Review of Liver Failure trials Research Report on Liver Failure

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hepatocyte Microbeads for Acute Liver Failure
HMB002 - Acute Liver Failure
Phase 1 / Phase 2UnknownKing's College Hospital NHS Trust172022-09-012022-08-08
Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients
Direct Peritoneal Resuscitation - End Stage Liver DIsease, Obesity
Phase 1UnknownUniversity of Colorado, Denver152022-02-012023-06-08
Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure
Mesenchymal Stem Cell - Liver Failure, Acute on Chronic
Phase 1 / Phase 2UnknownTianjin Weikai Bioeng., Ltd.452019-10-012019-03-20
Using Ex-vivo Normothermic Machine Perfusion With the Organox Metra™ Device to Store Human Livers for Transplantation
OrganOx Metra - End-stage Liver Disease
Phase 1UnknownUniversity Health Network, Toronto402015-07-012022-04-12
Pneumatic Reversible Portal Vein Diameter Modulation After Major Hepatectomy
MID-AVR - Liver Failure, Major Hepatectomy
Phase 1 / Phase 2UnknownAssistance Publique - Hôpitaux de Paris122015-04-182019-04-16
Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure
Conventional plus BM-MSC treatment, Conventional plus UC-MSC treatment, Conventional treatment - Liver Failure
Phase 1 / Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University2102013-07-012013-07-08
Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure
Conventional plus UC-MSC treatment, Conventional plus PE treatment, Conventional plus UC-MSC and PE therapy - Liver Failure
Phase 1 / Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University1202012-11-012013-02-28
Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Mobilization with G-CSF and Mozobil - End Stage Liver DIsease
Phase 1UnknownProteonomix, Inc.152012-10-012013-01-24
Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis
BMSC transplantation, conventional treatment & antivrial treatment - Liver Cirrhosis, End Stage Liver Disease
Phase 1 / Phase 2UnknownAir Force Military Medical University, China2402012-09-012012-11-12
Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis
PBSC transplantation, conventional treatment - Liver Cirrhosis, End Stage Liver Disease
Phase 1 / Phase 2UnknownAir Force Military Medical University, China2402012-09-012012-11-20
Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis
UC-MSC transplantation, conventional treatment - Liver Cirrhosis, End Stage Liver Disease
Phase 1 / Phase 2UnknownAir Force Military Medical University, China2402012-09-012012-11-20
Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study.
Sildenafil. - Hepatic Encephalopathy.
Phase 1 / Phase 2UnknownPost Graduate Institute of Medical Education and Research, Chandigarh502012-07-012014-01-07
Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis
Stem cell transplant - End Stage Liver Disease
Phase 1 / Phase 2UnknownKing Saud University502011-09-012011-08-09
Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure
Conventional plus MSC treatment, Conventional plus pacebo treatment - Liver Failure, Mesenchymal Stem Cells
Phase 1 / Phase 2UnknownBeijing 302 Hospital702009-03-012013-05-31
Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure
Recombinant human hepatocyte growth factor - Liver Failure, Acute
Phase 1 / Phase 2UnknownKyoto University, Graduate School of Medicine162005-09-012005-09-26

Narrower conditions

End Stage Liver Disease (7)  ·  Liver Cirrhosis (3)  ·  Liver Failure, Acute (2)  ·  Acute Kidney Injury (1)  ·  Acute-On-Chronic Liver Failure (1)  ·  Hepatic Encephalopathy (1)  ·  Hepatitis B (1)  ·  Obesity (1)  ·  Renal Insufficiency (1)

Broader conditions

Digestive System Diseases (15)  ·  Hepatic Insufficiency (15)  ·  Liver Diseases (15)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Fibrosis (3)  ·  Pathologic Processes (3)  ·  Nutritional and Metabolic Diseases (2)  ·  Blood-Borne Infections (1)  ·  Body Weight (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Central Nervous System Diseases (1)  ·  Communicable Diseases (1)  ·  DNA Virus Infections (1)

Interventions

Congresses as Topic (3)  ·  Antiviral Agents (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Sildenafil Citrate (1)  ·  Stem Cell Transplantation (1)  ·  plerixafor (1)

Sponsors

Air Force Military Medical University, China (3)  ·  Third Affiliated Hospital, Sun Yat-Sen University (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Beijing 302 Hospital (1)  ·  King Saud University (1)  ·  King's College Hospital NHS Trust (1)  ·  Kyoto University, Graduate School of Medicine (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Proteonomix, Inc. (1)  ·  Tianjin Weikai Bioeng., Ltd. (1)  ·  University Health Network, Toronto (1)  ·  University of Colorado, Denver (1)

Countries

China (7)  ·  United States (2)  ·  Canada (1)  ·  France (1)  ·  India (1)  ·  Japan (1)  ·  Saudi Arabia (1)

Top investigators

Daiming Fan (3)  ·  Anil Dhawan, Professor (1)  ·  Baburao Koneru, MD (1)  ·  David R Grant, MD (1)  ·  Fu-Sheng Wang, Professor (1)  ·  Hunter B Moore, M.D., P.hD. (1)  ·  Qi Zhang, Doctor (1)  ·  Radha K Dhiman, MD, DM, FACG (1)  ·  Tsutomu Chiba, M.D. (1)  ·  Zhi-Liang Gao, Doctor (1)

Results publications

PMID 17903050, PMID 19455046, PMID 30863450

NIH funding

2019 (1)